Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic
Identifieur interne : 000238 ( Pmc/Checkpoint ); précédent : 000237; suivant : 000239Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic
Auteurs : Xiaoli Hua ; Ming Gu ; Fang Zeng ; Huiping Hu ; Tao Zhou ; Yu Zhang ; Chen ShiSource :
- Journal of the American Pharmacists Association [ 1544-3191 ] ; 2020.
Abstract
To describe the pharmacy administration and pharmaceutical care in a module hospital during the coronavirus disease 2019 (COVID-19) epidemic and provide reference for domestic and foreign pharmacists participating in the epidemic prevention and control.
The study was performed in a Jianghan module hospital constructed at the Wuhan Convention and Exhibition Center in Wuhan, China. This is 1 of the first 3 module hospitals.
One thousand eight hundred forty-eight patients were admitted to the Jianghan module hospital, and 1327 cases (71.81% of the total number) were cured and discharged. Pharmacists have successfully completed the tasks of purchase, storage, and free distribution of drugs worth ¥1.03 million (approximately $146,000), reviewed about 20,000 electronic orders, provided one-on-one online medication consultation for 484 patients, and held 5 lectures on rational drug use knowledge, which could help reduce irrational drug use and minimize the risk involved.
The new COVID-19 “module” pharmaceutical care model is equipped with new features such as pharmacy emergency command group, organizational structure for pharmacy administration, electronic control of drug prescription, and “zero contact” pharmaceutical care relying on the new media platform “WeChat.” This platform provides relevant pharmaceutical care for patients, such as ensuring drug supply, setting up critical care drug trolleys, designing specific drug packaging bags, creating a module radio station to broadcast rational drug use information to the patients, and other aspects.
With the continuous improvement of the module hospital and the progress in in-depth knowledge about COVID-19, some aspects such as patient admission criteria and variety of drugs need to be adjusted depending on the actual situation.
The pharmacists provided pharmaceutical care for 1848 patients with mild COVID-19 disease. They not only ensured the timely supply of the drugs but also reduced the incidence of drug-induced risks through medication review and guidance, thereby improving patient compliance and helping the patients rebuild their confidence in overcoming the disease.
The new COVID-19 module pharmaceutical care model has played an important role in overcoming the epidemic situation of COVID-19 in China and thus can be implemented on a broader scale.
Url:
DOI: 10.1016/j.japh.2020.04.006
PubMed: 32336673
PubMed Central: 7146685
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:7146685Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic</title><author><name sortKey="Hua, Xiaoli" sort="Hua, Xiaoli" uniqKey="Hua X" first="Xiaoli" last="Hua">Xiaoli Hua</name></author><author><name sortKey="Gu, Ming" sort="Gu, Ming" uniqKey="Gu M" first="Ming" last="Gu">Ming Gu</name></author><author><name sortKey="Zeng, Fang" sort="Zeng, Fang" uniqKey="Zeng F" first="Fang" last="Zeng">Fang Zeng</name></author><author><name sortKey="Hu, Huiping" sort="Hu, Huiping" uniqKey="Hu H" first="Huiping" last="Hu">Huiping Hu</name></author><author><name sortKey="Zhou, Tao" sort="Zhou, Tao" uniqKey="Zhou T" first="Tao" last="Zhou">Tao Zhou</name></author><author><name sortKey="Zhang, Yu" sort="Zhang, Yu" uniqKey="Zhang Y" first="Yu" last="Zhang">Yu Zhang</name></author><author><name sortKey="Shi, Chen" sort="Shi, Chen" uniqKey="Shi C" first="Chen" last="Shi">Chen Shi</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">32336673</idno><idno type="pmc">7146685</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146685</idno><idno type="RBID">PMC:7146685</idno><idno type="doi">10.1016/j.japh.2020.04.006</idno><date when="2020">2020</date><idno type="wicri:Area/Pmc/Corpus">000697</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000697</idno><idno type="wicri:Area/Pmc/Curation">000697</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000697</idno><idno type="wicri:Area/Pmc/Checkpoint">000238</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000238</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic</title><author><name sortKey="Hua, Xiaoli" sort="Hua, Xiaoli" uniqKey="Hua X" first="Xiaoli" last="Hua">Xiaoli Hua</name></author><author><name sortKey="Gu, Ming" sort="Gu, Ming" uniqKey="Gu M" first="Ming" last="Gu">Ming Gu</name></author><author><name sortKey="Zeng, Fang" sort="Zeng, Fang" uniqKey="Zeng F" first="Fang" last="Zeng">Fang Zeng</name></author><author><name sortKey="Hu, Huiping" sort="Hu, Huiping" uniqKey="Hu H" first="Huiping" last="Hu">Huiping Hu</name></author><author><name sortKey="Zhou, Tao" sort="Zhou, Tao" uniqKey="Zhou T" first="Tao" last="Zhou">Tao Zhou</name></author><author><name sortKey="Zhang, Yu" sort="Zhang, Yu" uniqKey="Zhang Y" first="Yu" last="Zhang">Yu Zhang</name></author><author><name sortKey="Shi, Chen" sort="Shi, Chen" uniqKey="Shi C" first="Chen" last="Shi">Chen Shi</name></author></analytic><series><title level="j">Journal of the American Pharmacists Association</title><idno type="ISSN">1544-3191</idno><idno type="eISSN">1544-3450</idno><imprint><date when="2020">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Objectives</title><p>To describe the pharmacy administration and pharmaceutical care in a module hospital during the coronavirus disease 2019 (COVID-19) epidemic and provide reference for domestic and foreign pharmacists participating in the epidemic prevention and control.</p></sec><sec><title>Setting</title><p>The study was performed in a Jianghan module hospital constructed at the Wuhan Convention and Exhibition Center in Wuhan, China. This is 1 of the first 3 module hospitals.</p></sec><sec><title>Practice description</title><p>One thousand eight hundred forty-eight patients were admitted to the Jianghan module hospital, and 1327 cases (71.81% of the total number) were cured and discharged. Pharmacists have successfully completed the tasks of purchase, storage, and free distribution of drugs worth ¥1.03 million (approximately $146,000), reviewed about 20,000 electronic orders, provided one-on-one online medication consultation for 484 patients, and held 5 lectures on rational drug use knowledge, which could help reduce irrational drug use and minimize the risk involved.</p></sec><sec><title>Practice innovation</title><p>The new COVID-19 “module” pharmaceutical care model is equipped with new features such as pharmacy emergency command group, organizational structure for pharmacy administration, electronic control of drug prescription, and “zero contact” pharmaceutical care relying on the new media platform “WeChat.” This platform provides relevant pharmaceutical care for patients, such as ensuring drug supply, setting up critical care drug trolleys, designing specific drug packaging bags, creating a module radio station to broadcast rational drug use information to the patients, and other aspects.</p></sec><sec><title>Evaluation</title><p>With the continuous improvement of the module hospital and the progress in in-depth knowledge about COVID-19, some aspects such as patient admission criteria and variety of drugs need to be adjusted depending on the actual situation.</p></sec><sec><title>Results</title><p>The pharmacists provided pharmaceutical care for 1848 patients with mild COVID-19 disease. They not only ensured the timely supply of the drugs but also reduced the incidence of drug-induced risks through medication review and guidance, thereby improving patient compliance and helping the patients rebuild their confidence in overcoming the disease.</p></sec><sec><title>Conclusion</title><p>The new COVID-19 module pharmaceutical care model has played an important role in overcoming the epidemic situation of COVID-19 in China and thus can be implemented on a broader scale.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Gorbalenya, A E" uniqKey="Gorbalenya A">A.E. Gorbalenya</name></author><author><name sortKey="Baker, S C" uniqKey="Baker S">S.C. Baker</name></author><author><name sortKey="Baric, R S" uniqKey="Baric R">R.S. Baric</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Sugalski, G" uniqKey="Sugalski G">G. Sugalski</name></author><author><name sortKey="Murano, T" uniqKey="Murano T">T. Murano</name></author><author><name sortKey="Fox, A" uniqKey="Fox A">A. Fox</name></author><author><name sortKey="Rosania, A" uniqKey="Rosania A">A. Rosania</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cheng, B" uniqKey="Cheng B">B. Cheng</name></author><author><name sortKey="Shi, R F" uniqKey="Shi R">R.F. Shi</name></author><author><name sortKey="Du, D Y" uniqKey="Du D">D.Y. Du</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Wang, Y M" uniqKey="Wang Y">Y.-M. Wang</name></author><author><name sortKey="Cao, M" uniqKey="Cao M">M. Cao</name></author><author><name sortKey="Huang, F" uniqKey="Huang F">F. Huang</name></author><author><name sortKey="Wang, J" uniqKey="Wang J">J. Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yang, B" uniqKey="Yang B">B. Yang</name></author><author><name sortKey="Fan, H J" uniqKey="Fan H">H.-J. Fan</name></author><author><name sortKey="Shi, L" uniqKey="Shi L">L. Shi</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Pharm Assoc (2003)</journal-id><journal-id journal-id-type="iso-abbrev">J Am Pharm Assoc (2003)</journal-id><journal-title-group><journal-title>Journal of the American Pharmacists Association</journal-title></journal-title-group><issn pub-type="ppub">1544-3191</issn><issn pub-type="epub">1544-3450</issn><publisher><publisher-name>American Pharmacists Association®. Published by Elsevier Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32336673</article-id><article-id pub-id-type="pmc">7146685</article-id><article-id pub-id-type="publisher-id">S1544-3191(20)30153-9</article-id><article-id pub-id-type="doi">10.1016/j.japh.2020.04.006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Hua</surname><given-names>XiaoLi</given-names></name></contrib><contrib contrib-type="author" id="au2"><name><surname>Gu</surname><given-names>Ming</given-names></name></contrib><contrib contrib-type="author" id="au3"><name><surname>Zeng</surname><given-names>Fang</given-names></name></contrib><contrib contrib-type="author" id="au4"><name><surname>Hu</surname><given-names>Huiping</given-names></name></contrib><contrib contrib-type="author" id="au5"><name><surname>Zhou</surname><given-names>Tao</given-names></name><xref rid="cor1" ref-type="corresp">∗</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Zhang</surname><given-names>Yu</given-names></name><email>whxhzy@163.com</email></contrib><contrib contrib-type="author" id="au7"><name><surname>Shi</surname><given-names>Chen</given-names></name><email>29136909@qq.com</email><xref rid="cor1" ref-type="corresp">∗</xref></contrib></contrib-group><author-notes><corresp id="cor1"><label>∗</label><bold>Correspondence:</bold> Chen Shi, PhD, or Yu Zhang, PhD, Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China. <email>29136909@qq.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>10</day><month>4</month><year>2020</year></pub-date><pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="epub"><day>10</day><month>4</month><year>2020</year></pub-date><history><date date-type="received"><day>24</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>1</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>© 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Pharmacists Association®</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0010"><sec><title>Objectives</title><p>To describe the pharmacy administration and pharmaceutical care in a module hospital during the coronavirus disease 2019 (COVID-19) epidemic and provide reference for domestic and foreign pharmacists participating in the epidemic prevention and control.</p></sec><sec><title>Setting</title><p>The study was performed in a Jianghan module hospital constructed at the Wuhan Convention and Exhibition Center in Wuhan, China. This is 1 of the first 3 module hospitals.</p></sec><sec><title>Practice description</title><p>One thousand eight hundred forty-eight patients were admitted to the Jianghan module hospital, and 1327 cases (71.81% of the total number) were cured and discharged. Pharmacists have successfully completed the tasks of purchase, storage, and free distribution of drugs worth ¥1.03 million (approximately $146,000), reviewed about 20,000 electronic orders, provided one-on-one online medication consultation for 484 patients, and held 5 lectures on rational drug use knowledge, which could help reduce irrational drug use and minimize the risk involved.</p></sec><sec><title>Practice innovation</title><p>The new COVID-19 “module” pharmaceutical care model is equipped with new features such as pharmacy emergency command group, organizational structure for pharmacy administration, electronic control of drug prescription, and “zero contact” pharmaceutical care relying on the new media platform “WeChat.” This platform provides relevant pharmaceutical care for patients, such as ensuring drug supply, setting up critical care drug trolleys, designing specific drug packaging bags, creating a module radio station to broadcast rational drug use information to the patients, and other aspects.</p></sec><sec><title>Evaluation</title><p>With the continuous improvement of the module hospital and the progress in in-depth knowledge about COVID-19, some aspects such as patient admission criteria and variety of drugs need to be adjusted depending on the actual situation.</p></sec><sec><title>Results</title><p>The pharmacists provided pharmaceutical care for 1848 patients with mild COVID-19 disease. They not only ensured the timely supply of the drugs but also reduced the incidence of drug-induced risks through medication review and guidance, thereby improving patient compliance and helping the patients rebuild their confidence in overcoming the disease.</p></sec><sec><title>Conclusion</title><p>The new COVID-19 module pharmaceutical care model has played an important role in overcoming the epidemic situation of COVID-19 in China and thus can be implemented on a broader scale.</p></sec></abstract></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Gu, Ming" sort="Gu, Ming" uniqKey="Gu M" first="Ming" last="Gu">Ming Gu</name><name sortKey="Hu, Huiping" sort="Hu, Huiping" uniqKey="Hu H" first="Huiping" last="Hu">Huiping Hu</name><name sortKey="Hua, Xiaoli" sort="Hua, Xiaoli" uniqKey="Hua X" first="Xiaoli" last="Hua">Xiaoli Hua</name><name sortKey="Shi, Chen" sort="Shi, Chen" uniqKey="Shi C" first="Chen" last="Shi">Chen Shi</name><name sortKey="Zeng, Fang" sort="Zeng, Fang" uniqKey="Zeng F" first="Fang" last="Zeng">Fang Zeng</name><name sortKey="Zhang, Yu" sort="Zhang, Yu" uniqKey="Zhang Y" first="Yu" last="Zhang">Yu Zhang</name><name sortKey="Zhou, Tao" sort="Zhou, Tao" uniqKey="Zhou T" first="Tao" last="Zhou">Tao Zhou</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000238 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000238 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:7146685
|texte= Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:32336673" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |